MedTrace Logo

An Observational Study to Analyze the Prescription Pattern of Sugammadex and Its Effectiveness and Safety

NCT05788718 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 6458

Last updated 2026-04-13

No results posted yet for this study

Summary

The purpose of this observational study is to evaluate patients who are planning to administer sugammadex after rocuronium or vecuronium is used.

The main questions it aims to answer are:

1. Prescription pattern of sugammadex
2. Effectiveness and safety of sugammadex

Since this study is observational, only data generated under daily treatment are to be collected, and no additional tests or drug administration is conducted for the study. The patients are observed from baseline to 24 hours after the initial administration of sugammadex.

Conditions

  • Postoperative Complications
  • Neuromuscular Blockade
  • Anesthesia

Interventions

DRUG

Sugammadex

As this is a non-interventional study designed to collect data as part of routine clinical practice, the type and dose of neuromuscular blocking agents are all based on the clinician's judgment.

Sponsors & Collaborators

  • Boryung Pharmaceutical Co., Ltd

    lead INDUSTRY

Principal Investigators

  • Choon-Hak Lim, MD · Department of Anesthesiology and Pain Medicine, Korea University Medical Center, Seoul, Korea.

Eligibility

Min Age
19 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2023-04-11
Primary Completion
2025-05-08
Completion
2025-05-08

Countries

  • South Korea

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05788718 on ClinicalTrials.gov